Hematology and Oncology
Home Hematology and Oncology
Oct4 Found to Be a Prognostic Marker for Digestive Cancers
Elevated Oct4 levels tied to poor overall, disease-free, and recurrence-free survival
Thromboembolic Events Common With Chemo for Bladder Cancer
Findings in patients with muscle invasive bladder cancer who undergo neoadjuvant chemotherapy
Discussing Opioid Risks With Patients Reduces Misuse
Sixty percent lower rate of saving of pills among patients who talked to their doctor about risks
Intermittent Hypoxia Promotes Lung Tumor Cell Aggressiveness
IH-induced exosomes from mice significantly promote TC1 malignant properties
USPSTF Continues to Recommend Against Thyroid Cancer Screening
Widespread routine thyroid cancer screening can lead to overdiagnosis, overtreatment
Small Increase in Hematocrit With Implantable Testosterone
Statistically significant 2.2 percent increase in mean hematocrit unlikely to be clinically relevant
Updated Index Predicts Survival in NSCLC With Brain Metastases
Significant prognostic factors include four factors from earlier index, plus EGFR and ALK alterations
HOMA2-IR Tied to Hepatocellular Carcinoma Risk in Hepatitis B
HOMA2-IR independently linked to HCC in patients without overt metabolic abnormalities
Poor Sensitivity for HPV 16/18 in Minor Abnormal Cytology
Review: pooled sensitivity of HPV 16/18 genotyping for CIN3+ about 70 percent for ASC-US or LSIL
Palbociclib Efficacious in Metastatic Breast Cancer
Palbociclib-letrozole combination slows disease progression
